# A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice

> **NCT05021562** · — · COMPLETED · sponsor: **Takeda** · enrollment: 354 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Niraparib

## Key facts

- **NCT ID:** NCT05021562
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-13
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05021562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05021562, "A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05021562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*